INTRODUCTION DIAGNOSIS
Secondary insomnia (SI) warrants special attention, Secondary insomnia is characterised by a complaint because it is the most common form of insomnia, of poor sleep that is either precipitated or agaccounting for approximately three-quarters of gravated by another disorder (medical or psycases seen in both patient and general populations. chiatric) or substance. As SI is a common symptom Sleep is vulnerable to disruption by a wide variety of a variety of disorders, it does not typically receive of conditions. This review begins with a general separate diagnosis unless severe enough to warrant discussion of SI diagnosis and treatment. Then, independent clinical attention [1, 2] . Specific guidethe focus is narrowed, providing more detailed lines for determining severity vary, but generally discussion of some of the more common primary agree that insomnia is severe if it results in significant disorders causing SI. The review concludes by introsubjective distress and/or social or occupational ducing a new heuristic model of SI.
impairment. Distinguishing between primary insomnia (PI) and SI can be difficult. Insomnia is frequently accompanied by another condition, and it is not always clear whether the accompanying symptoms and need to be ruled out [1, 2] . Insomnia for diagnosing insomnia. The DSM-IV and the ICSD provide some specific guidelines for diagnosing SI, can also have dual etiology, such that it is partially due to the primary condition and partially inbut unfortunately, these are not consistent across the two systems. These guidelines may also lack dependent.
Polysomnographic (PSG) evaluation is not gensufficient detail to be clinically useful. Across several clinical settings, Buysse et al. [9] found only moderally recommended for the assessment of insomnia, but may be necessary to rule out other sleep erate agreement (kappas ranged from .26 to .80) between sleep specialists and general clinicians using disorders [3] . Self-report is the most practical means of evaluating SI. Therefore, obtaining an accurate DSM-IV criteria to diagnose individuals reporting insomnia complaints. The establishment of clear, history from the patient is the key to accurate diagnosis [4] . Information pertaining to the onset detailed guidelines that are consistent across systems would clarify assessment. The Discussion secand course of the insomnia and the other disorder can help to establish the etiology of the sleep tion will return to an exploration of the difficulties in distinguishing comorbidity from SI, wherein an complaint. Secondary insomnia is indicated when the onset of the insomnia coincides with or shortly alternative diagnostic scheme that acknowledges the ambiguity inherent in diagnosing SI is proposed. follows that of the other disorder. It is also indicated when the course of the insomnia mimics that of the other disorder, remitting or diminishing in severity as the primary condition remits. Frequently,
PREVALENCE
SI can be directly linked to some feature of the Epidemiological estimates of the prevalence of sleep primary disorder (i.e. joint pain due to arthritis difficulties in the general population range from resulting in disrupted sleep). Insomnia can also 10-48% [4,5, 10, 11] . Although very little data speprecede another disorder (i.e. a patient may develop cifically targets SI, the available evidence suggests it depression following 6 months of insomnia) [5] .
is much more common than PI, accounting for Whether it is causal or prodromal in such cases is 70-90% of insomnia (variously defined) reported unclear.
by the general population [4,5,10,11] and up to 73% of insomnia diagnosed (using ICSD criteria) in sleep
CLASSIFICATION SYSTEMS
disorders centers [12] [13] [14] [15] . Some caution should be exercised in interpreting these data, because they The International Classification of Diseases (ICDmay overestimate the occurrence of SI. Much of 10) [8] , the Diagnostic and Statistical Manual of the epidemiological research on insomnia is flawed Mental Disorders-Fourth Edition (DSM-IV) [1] , and by inadequate definitions of insomnia and inadequate the International Classification of Sleep Disorders efforts to rule out other sleep disorders or to (ICSD) [2] all agree that insomnia is a symptom distinguish SI from comorbidity. Epidemiological recommon to a variety of disorders. They disagree, search that takes these flaws into account is needed. however, on whether SI warrants separate classification. The ICD-10 does not distinguish SI from PI; the DSM-IV and ICSD do make this distinction.
CAUSES OF SECONDARY
The ICD-10 categorises both SI and PI as ''non-
INSOMNIA
organic insomnia''. For SI, this categorisation is given in addition to that of the primary disorder when Psychiatric secondary insomnia the complaint of insomnia ''dominates the clinical Psychiatric causes of SI include anxiety, depression, picture''. The DSM-IV provides broad classification panic disorder, adjustment disorders, somatoform based on SI's three main causes: insomnia related disorders, and personality disorders [1, 2, 8] . Epito another mental disorder; sleep disorder due to demiological research has found comorbidity rates a general medical condition, insomnia type; and of 40-50% between insomnia and psychiatric dissubstance-induced sleep disorder, insomnia type.
tress [4, 5, 10] . In one study, more than 70% of The ICSD provides the most detailed classification, individuals with a mood disorder complained of listing 19 psychiatric and medical disorders and insomnia [4] . In sleep disorders centers, psychiatric substances that may result in SI.
All three systems provide some basic guidelines SI was the most frequent diagnosis (35-50%) among 
Medical conditions
A wide variety of medical conditions lead to SI, medications (Table 1) . Common non-prescription including asthma, pulmonary disease, heart disease, substances, such as caffeine, nicotine and alcohol arthritis, renal disease, obstructive airway disease, can also result in sleep difficulties [27, 28] . Over-theback problems, headaches, Alzheimer's disease, and counter medications containing caffeine can effect seizures [16] [17] [18] [19] [20] . The prevalence of medical SI is sleep (e.g. Anacin, Excedrin) as can some nasal difficult to estimate, but some data is available for decongestants and pain medications. Medication specific disorders. Monjan and Foley found older response is highly individualised and whether a adults with stroke or heart disease were about patient exhibits insomnia for a given medication twice as likely to develop insomnia within 3 years depends on dosage level, time of administration, than were older controls [21] . Almost half of cirand age [18, 29, 30] . Psychoactive substances that rhotic and over one third of chronic renal failure may induce SI include: alcohol, amphetamines, cafpatients report disturbed sleep [22] . Sleep disorders feine, cannabis, cocaine, nicotine, opiods and sedcenters data (7 studies, combined n=2249) found atives. These substances can effect sleep through that on average medical SI accounted for 5.8% the direct physiological effects of ingestion (i.e. of individuals complaining of insomnia [10,13-15, arousal) and/or by disrupting sleep patterns [31] . 23-25]. Determining which aspect of the medical Withdrawal from a substance can also result in disorder is actually causing the SI is particularly insomnia [31] . important. Medical SI can arise due to pain, psychological stress, and/or concurrent medication [7] . Different medical conditions affect sleep in different
OLDER ADULTS
ways. Based on self-report, Kaye, Kaye and Madow [26] found maintenance insomnia was typical of Secondary insomnia is more common and more cancer patients; while onset and/or terminal insevere in older adults for a multitude of reasons. somnia was typical of cardiac patients.
Age can arise, however, from adding pharmacological disrupted sleep patterns [35] . treatment to the regimen of patients already underOlder adults may also be particularly vulnerable going treatment for primary illnesses. Concurrent to psychiatric SI. Guerro and Crocq [36] examined medications should be carefully considered before an older (over age 65) and a younger (under age instituting pharmacological treatment. Because 55) group of depressed individuals matched for many medications (benzodiazepines and antiseverity of mood disturbance and found more fredepressant drugs) are metabolised by the cytoquent and more severe insomnia in the older group. chrome oxidase P450 system in the liver, patients Other psychiatric threats are also more common taking several prescribed drugs utilising this system in older adults. For example, bereavement is a risk may be at an increased risk of side-effects and factor for insomnia, and the elderly are more likely toxicity [39] . Older patients for whom polyto experience the death of a spouse, other loved pharmacy is a common occurrence may be parone or close friend. Other factors, such as reticularly susceptible. Hypnotics are recommended tirement, social isolation and restricted movement for short-term use only, because their effectiveness resulting from disability, occur more frequently in diminishes over time. Tolerance and dependence older adults and may affect sleep by provoking can also develop, particularly for some of the older anxiety or depression [37] .
benzodiazepines with longer half lives (i.e. now being conducted may demonstrate that the newer, shorter-acting hypnotics (zaleplon and zolpidem) also provide adequate long-term insomnia control.
TREATMENT Psychological treatments
Both pharmacological and behavioral interventions are used to treat PI. Secondary insomnia treatment, Primary insomnia [41, 42] responds well to psychological intervention. Research has just begun to however, is usually directed at the primary disorder. Typically, SI receives direct treatment only when examine such interventions for SI, and so far, the results have been encouraging. There are a variety of the insomnia is severe or does not respond to [46] psychological or behavioral treatments for insomnia. group psychotherapy, marital therapy, occupational therapy, sleep medication, progressive relaxation, Table 2 contains brief descriptions of the most common treatments: cognitive, cognitive behavioral, stimulus control and biofeedback. Rating their overall quality of sleep on a 0 to 8 scale, the patients relaxation, sleep restriction and stimulus control. demonstrated significant improvement from pretreatment (mean=1.6, SD=0.2) to post-treatment
Efficacy of psychological interventions
(mean=6, SD=0.4) and maintained these gains at Only a handful of case studies and a few randomised 6-month follow-up (mean=6.9, SD=0.4). group studies have been conducted. Five case studTo date, there have been three randomised group ies have shown insomnia improves following psystudies of SI [52-54]. Cannici et al.
[52] evaluated chological treatment for SI due to cancer [47] , progressive relaxation (PR) with patients with varichronic pain [48] , depression and pain [38] , heous cancer diagnoses. Thirty patients (mean age of mophilia [49] and multiple medical problems [50] . 56 years) were assigned at random to either usual A variety of treatments were employed in these medical care or usual care plus three sessions of studies (i.e. relaxation, slow deep breathing, sleep PR. Pre and post-treatment data were collected for restriction, stimulus control, imagery). In a multiple 3 days prior to 3 days of consecutive treatment; 3-baseline study, Morin et al. [16] had three chronic month follow-up data were also collected. Latency pain patients continue their usual pain care (i.e.
to sleep improved significantly from 124 min prephysical therapy, nerve blocks) during 6 weeks treatment to 29 min post-treatment in the PR group, of psychological treatment consisting of stimulus but remained unchanged in a control group. The control and sleep restriction. Each patient reported PR group maintained this improvement at the 3-improved sleep (i.e. decreased time to fall asleep, month follow-up (latency to sleep was 33 min), less and shorter awake times at night) following while the comparison group remained unchanged. treatment and maintained these improvements at
The improvements in this measure were large and 6 months follow-up. All-night PSG sleep studies clinically meaningful. Unfortunately, this is the only at pre and post-treatment corroborated the selfmeasure demonstrating statistically significant treatreport data. Interestingly, over the course of treatment gains. Most of the other sleep measures (e.g. ment, two of the three patients also improved total sleep time, number of awakenings during the substantially on measures of depression and anxiety.
night, rated sleep satisfaction) and pain ratings imTan et al. [51] treated 20 psychiatric inpatients with proved in the PR group, but the differences were not severe insomnia for an average of 5 weeks using statistically significant, perhaps due to low power as multimodal, individualised treatment, involving a result of small sample size.
Currie et al.
[53] evaluated cognitive behavioral some combination of individual psychotherapy, therapy (CBT) in 60 chronic pain patients (mean chronic pain acting as the most common primary disorders. Participants were assigned at random to age of 45 years). Over two-thirds of these patients either treatment or a delayed treatment control (72%) experienced chronic back pain; the remainder group. Treatment consisted of four sessions of experienced neck pain, lower limb or pelvic region hybrid passive relaxation, stimulus control and pain. Thirty-two participants were assigned to CBT, sleep-hygiene instructions. At post-treatment and consisting of sleep restriction, stimulus control and 3-month follow-up, the treated group improved relaxation, and 28 were assigned to a wait list significantly on three sleep measures: wake time control (WLC). Therapy was administered in a during the night, sleep efficiency (ratio of time slept group format over a 7-week period. Overall, CBT to time spent in bed ×100), and rated quality of participants demonstrated significant improvement sleep (1=very good to 5=excellent). From baseline on self-report measures of sleep onset latency, to follow-up, wake time for the treated group went waketime-after-sleep onset, sleep efficiency, and from 87.3 to 56.4 min, sleep efficiency went from sleep quality compared with WLC participants, and 66.7 to 77.0%, and rated quality of sleep went from these improvements were maintained at 3-month 2.7 to 3.2%. The control group showed no significant follow-up. Sleep onset latencies for the CBT parimprovement. There were no differences in treatticipants were reduced by an average of 26.6 min ment response for medical versus psychiatric SI. from pre-treatment to post-treatment (54.7 min
Because older insomniacs are typically difficult to to 28.1 min) and remained improved over pretreat, these results are highly encouraging, partreatment at follow-up (27.8 min). Sleep efficiency ticularly given that the treatment was conducted for the CBT participants increased significantly from briefly in only four sessions. Additional research on 72% at pre-treatment to 85% at post-treatment and the efficacy of psychological treatments for SI is maintained at 84% at follow-up. Wake-after-sleep needed. onset was reduced by 48.7 min from baseline to post-treatment in CBT participants, and again, this improvement was maintained at follow-up (51.6 min). Both CBT and WLC participants dem-
Pharmacological versus psychological
onstrated small, but significant improvement in selftreatment rated sleep quality from pre-treatment to posttreatment; however, only the CBT participants Both treatments provide effective short-term manmaintained this improvement at follow-up. There agement of insomnia. Unfortunately, hypnotic medwas no significant difference between the treated ications lose effectiveness over time. Because and non-treated groups in total number of awakeninsomnia is often a chronic condition, behavioral ings following treatment. Total sleep time (TST) was therapy may be the best treatment option. In a not increased; however, this analysis approached randomised, placebo-controlled clinical trial (n= significance. The CBT participants also dem-78), Morin et al. evaluated the efficacy of behavioral onstrated a significant reduction in nocturnal motor and pharmacological (temazepam) therapies, singly activity levels from baseline to post-treatment, sugand combined, in older (mean age, 65 years) ingesting they were having a more restful sleep period. dividuals with chronic insomnia. Treatment lasted Lichstein et al. [54] have recently conducted the 8 weeks and follow-ups were conducted at 3, 12 only randomised study focusing specifically on older and 24 months. Behavioral intervention alone was adults. The study examined 44 older adults (age 58 found to be more effective in sustaining sleep imor older) who reported at least a 6-month history provements over time than either medication alone of insomnia. Subjects had to be sleep-medication or the two treatments combined [40] . Some caufree and qualified as having SI based on the following tion, however, should be used in interpreting the criteria: (i) a plausible causal link could be established results of this study. As medication and behavioral between the psychiatric or medical disorder; (ii) treatment were administered and discontinued coninsomnia onset closely followed the onset of the currently, additional research is needed to deterprimary disorder; and/or (iii) variations in the semine whether other methods of combining verity of the insomnia closely followed variations in behavioral and drug therapies will produce similar the primary disorder. Medical and psychiatric SI results. Likewise, this study used an older benzodiazepine and, therefore, does not tell us whether were equally represented with depression and the combination of a newer non-benzodiazepine depression or as a prodromal symptom is debatable. hypnotic (zaleplon, zolpidem) and behavioral therIndividuals who suffer recurrent depression often apy would be effective. Finally, this study does not have more pronounced sleep disturbance, which take into consideration individuals who experience may occur several weeks prior to recurrence and intermittent insomnia and as a result, use medication proceed other depressive symptoms [56]. intermittently.
Anti-depressants, specifically selective serotonin reuptake inhibitors (SSRIs: fluoxetine, sertraline, General secondary insomnia treatment paroxetine, fluvoxamine, citalopram), are comguidelines monly used to treat depression [57] . Unfortunately, SSRIs stimulate serotonin-2 (5-HT-sub-2) receptors • Aggressively treat the primary condition and can cause changes in sleep architecture, re-• Treat the insomnia as well using psychological sulting in insomnia. For example, research has interventions:
shown disturbed sleep (prolonged REM latency and • they are effective and provide good longsuppressed REM sleep) in fluoxetine treated determ maintenance pressed patients [58] . When fluoxetine was com-• unlike medication, they are not likely to pared with nefazodone in depressed outpatients in cause any serious, adverse effects three separate 8-week trials, both were equally • SI can rarely be definitively diagnosed, effective anti-depressants, but fluoxetine disturbed because causality is extremely difficult to sleep (decreasing sleep efficiency -SE, increasing establish awakenings, decreasing total REM sleep). Ne-• treating the insomnia will not aggravate, fazodone, which has a pharmacological profile difand may even result in, improvement in ferent from most types of anti-depressants, the primary condition improved sleep (increasing SE, decreasing awakenings, increasing total REM sleep Trazodone has also been shown to be effective, rapid eye movements, particularly during the first both objectively and subjectively, in improving sleep REM period. Pathology involves disturbed phase in depressed patients who developed insomnia durrelationships of circadian rhythms. Frequent ing treatment with Brofaromine, a selective and awakenings and early morning waking are hallmark reversible monoamine oxidase (MAO) inhibitor. In complaints of depression-related insomnia. Ala study comparing dose response to trazodone though insomnia typically mimics the course of the (50 mg vs 75 mg vs 100 mg), 100 mg/day was found depression, it can also precede onset [4, 5] and most effective in sleep-disturbed depressed patients persist after remission [1, 2] . In Ford and Kamerow's (n=33) [64] . Psychological interventions may be often cited epidemiological study, complaints of particularly useful and have been shown to efinsomnia during the initial interview predicted the fectively treat insomnia [26, 32] and depression [65] , development of depression by 1-year follow-up [5] . Whether insomnia is interpreted as a risk factor for separately. Research investigating the concurrent treatment of both conditions using behavioral techduring NREM, alpha-delta activity and occasional periodic limb movements. Subjective complaints of niques is definitely warranted. daytime sleepiness and fatigue, however, are not supported by multiple sleep latency tests (MSLT).
Anxiety
Research suggests SWS disturbance contributes to Characteristic complaints include frequent awakencomplaints of non-restorative sleep [76] . When ings which may be accompanied by anxiety dreams.
treating insomnia related to SI, adequate pain conInsomnia is often due to conditioning, and worry trol and sleep habits should be achieved before about inability to sleep may be present. Polymedication is prescribed [77] . Tricyclic antisomnography generally reveals non-specific findings.
depressants, trazodone, and selective serotonin A single treatment with a benzodiazepine is not re-uptake inhibitors may be helpful. generally recommended for anxiety, but may benefit patients with generalised anxiety or panic [39] . Very little research has specifically targeted anxiety. In a
Rheumatoid arthritis (RA)
5-week single-blind study of trazodone, Arriaga et Morning stiffness, unrefreshing sleep and fatigue al. [61] found improvement in both anxiety and are common complaints. Polysomnography often insomnia related to improvement in sleep PSG reveals sleep fragmentation and reduced sleep ef-(increased slow-wave sleep; SWS). Psychological ficiency, alpha-delta sleep and K-alpha complexes interventions may be particularly helpful in relieving [78] . Research is needed to determine if imbalances the physical tension (relaxation) and/or the disin cytokine networks are related to disturbed sleep turbed thinking patterns (cognitive therapy) often and daytime fatigue. In a double-blind, cross-over seen in anxious patients. study, Walsh et al. [79] found triazolam increased TST and decreased daytime sleepiness and morning stiffness in RA patients compared to placebo; ob-
Medical
jective measures of sleep fragmentation were unchanged. The results of a study by Hardo et al. [80] Chronic pain however, suggest the use of hypnotics may be Pain frequently causes insomnia [66, 67] , particularly questionable as arthritic patients (n=165) receiving for cancer [68, 69] , back pain [70] and headache [71] .
night sedation had more pain than those who did Approximately 50-70% of pain patients experience not as evidenced by greater usage of codeine (34% insomnia [16, 72, 73] . Morin et al. [16] found poor compared with 18%). sleep coincided with or followed the onset of pain in 90% of the patients experiencing insomnia. Pain and insomnia are often reciprocal [74, 75] . For exDementia ample, in osteoarthritis, insomnia may worsen dayAlzheimer's disease and other dementias are fretime pain by lowering pain thresholds and promoting quently associated with sleep disturbance, parpoor sleep posture resulting in joint strain [74] .
ticularly sundowning [81] . Hypnotics (low doses of Polysomnographic findings in 25 headache patients short-acting benzodiazepines), anti-histamines, and (only seven had insomnia complaints) found inanti-depressants are commonly used in nursing stances of headache causing insomnia, insomnia homes as are anti-psychotic drugs such as halcausing headache, and insomnia and headache exoperidol and resperidol. Dementia patients are paracerbating each other [75] . Insomnia and pain asticularly susceptible to the cognitive side effects of sociated with fibromyalgia and rheumatoid arthritis such drugs and should be carefully monitored for may benefit from antidepressant drugs. As preconfusion. Despite their common use, anti-hisviously discussed, CBT has been shown to be effecttamines have not been thoroughly researched. A ive for insomnia secondary to chronic pain and in few studies, however, have shown them to be fact, is one of the few conditions for which CBT sedative compared with placebo and comparable has been systematically studied [54] .
to benzodiazepines with similar cognitive effects [39]. Non-pharmacological interventions can be helpful and should focus on improving daytime
Fibromyalgia
Sleep is often light and accompanied by physical activity, providing sufficient light exposure and ensuring a proper night-time sleep environment (one discomfort (musculoskeletal pain, chronic fatigue). Characteristic PSG results include alpha activity that minimises noise and other disruptions).
accompanied by daytime drinking or physical tol-
Parkinson's disease (PD)
erance or dependence [2] . Alcohol appears to have Secondary insomnia may result from the muscle a positive effect on sleep at the beginning of the tremors and stiffness associated with neurological night, but this is countered by worse sleep at the disease [6] and is the most common sleep problem end of the night. Typical PSG results reveal reduced in PD (seen in 60-90% of patients) [2] . Charwake time and REM, and increased SWS for first acteristic complaints include sleep fragmentation 3-4 h of sleep followed by wakefulness and REM and daytime sleepiness. Neurochemical changes, rebound during the last 2-3 h of sleep [2] . Alcohol's including alterations in dopaminergic, serotonergic initial, positive effect may be the reason some and norepinephrin systems, can interfere with the patients believe very strongly that alcohol helps sleep-wake cycle, reducing REM and SWS [2] . Toxthem sleep better. Withdrawal from alcohol also icity caused by dopamine agonists and antidisturbs sleep, resulting in very short TST on some cholinergic medications used to treat PD can disturb nights, REM rebound for the first few days and sleep. Medication-induced sleep complaints are seen a profound reduction or even absence of SWS. in up to 80-90% of patients treated with levodopa Recovery of SWS occurs gradually (and occasionally and bromocriptine [2] . Insomnia may improve when not at all), taking take up to 2 years in some cases. levodopa administration is restricted to earlier Tolerance to withdrawal and alcohol cravings are hours and may even disappear altogether when it inversely correlated with SWS. As benzodiazepines is discontinued. In some cases, however, dopamine are not generally recommended for patients with agonists improve sleep by reducing rigidity. Deaddictive potential, non-pharmacological inmentia and depression frequently accompany PD terventions may prove particularly helpful [84] . Benand contribute to insomnia. Limb movements, zodiazepines may be useful, however, for treatment tremor and/or medication-induced myoclonus can of acute alcohol withdrawal. Some clinicians prefer cause arousal, while bradykinesia and rigidity can to use sedating antidepressant drugs, but the efresult in abnormal body shifting during the night.
fectiveness of this approach has yet to be demSleep apnea should be ruled out as abnormal motor onstrated [39] . activity in the upper airway and chest can disrupt breathing. Complaints of sleep disturbance often increase as PD progresses. There are no distinctive
DISCUSSION
PSG features in PD [2] .
According to self-report data, the rate of PD
Proposed model of secondary insomnia
amongst 153 patients and their spouses was almost double that of 103 healthy, age-matched controls Conferring the diagnosis of SI rests on the ability [82] . Insomnia was attributed to the physiological to assert causal inference: condition A (medical, effects of PD (pain, tremor, rigidity, excessive sweatpsychiatric or substance) causes condition B (sleep ing, nocturia), medications used in treatment (e.g. disturbance). Though clinicians and researchers levodopa, selegiline) and associated psychiatric disalike may not dwell on philosophy of science issues tress (i.e. depression). Both PD patients and their in determining such diagnoses, the present context spouses reported high levels of depressive sympprovides such an opportunity, and careful analysis toms. The burden of taking care of someone with of this matter may help illuminate ambiguity and a chronic illness was evident in the slightly higher better prepare those entrusted with diagnostic derate of insomnia in the spouses than in the patients.
cisions. When rendering a diagnosis, it always con-A review of the literature revealed only one study cerns an individual patient, so that models of that failed to report elevated levels of insomnia randomised clinical trial methodology that best proin PD patients. Comparing PD patients with agetect internal validity and causal inference do not matched controls, Factor et al. [83] found only a apply. Single-subject designs, particularly the Asmall increment in insomnia in the PD patients.
B-A-B design [85] , also justify causal inference and are salient to the present discussion. We can be Substance confident of our diagnosis of SI in the unlikely event of a naturally occurring experimental design. Such
Alcohol abuse
an example might occur with a cancer patient who Self-prescribed use of ethanol as a sedative is distinct from alcoholism, because it is not typically reports a history of always experiencing insomnia when the cancer is active and never having difficulties months, most patients cannot provide a reliable accounting of the course of the two disorders and sleeping when the cancer is in remission.
In practice, the conditions needed to assert causal their relative sequence. Lichstein [86] recently proposed a heuristic inference for SI are almost never present. It is easy to establish comorbidity, wherein, two disorders comodel that more accurately maps onto the reality of diagnosing secondary insomnia (Fig. 1) . The model occur but neither necessarily owns causal influence over the other. From a philosophy of science point divides SI into three distinct types: absolute, partial and specious. Absolute SI requires the insomnia to of view, it is usually impossible to render a definitive diagnosis of SI. Complicating this matter is the be under the complete control of the primary condition (i.e. chronic headache pain causing inexclusive reliance on the historical report of the patient in determining the origin and course of somnia). Absolute SI corresponds to the customary meaning of the term SI, and in our opinion, this is the "primary" and "secondary" disorders. In our experience, if this history has lasted more than 6 uncommon. Absolute SI is most likely to be found in acute conditions, but as the primary condition Unfortunately, SI is a complex disorder and assessing and treating it is often challenging. Detailed guidelines becomes chronic, the strong causal link between it and the sleep disturbance fades.
that are consistent across the three main classification systems (ICD-10, DSM-IV and ICSD) would go a long Partial SI occurs when only one of the conditions required for absolute SI is met. Two versions of way to help clarify diagnosis. The proposed model of SI was introduced not to replace but to supplement partial SI are possible: (i) a pre-existing PI may be exacerbated by a primary condition; or (ii) insomnia these systems and to provide a basis for more theoretically-oriented discussion of SI. Treatment is created by a primary condition may acquire some degree of functional independence over time. Partial typically directed at the primary disorder, but does not always improve the insomnia. As a result, direct SI takes into account that PI and SI are not mutually exclusive conditions. For example, a patient may SI treatment is often necessary and according to recent evidence, may even improve the primary have a 10-year history of difficulty falling asleep 3 or 4 nights a week, but may now be experiencing condition. Behavioral interventions offer promise as a primary treatment for SI and may in fact be the difficulty every night due to the onset of a major depressive episode. The third variety, specious SI, best approach to treating SI. They provide good longterm symptom management and unlike medications, refers to situations in which absolute or partial SI are wrongly diagnosed. Comorbid insomnia is are not likely to interfere with treatment of the primary condition, contribute to polypharmacy, or mistaken for SI. Unfortunately, the diagnostician is in the precarious state of never being able to verify cause other serious, adverse effects. any one of these varieties, and no matter which SI type is asserted, neither of the other two can Practice Points be ruled out. Treatment response of the sleep Basic secondary insomnia (SI) diagnostic guidedisturbance provides post hoc clues as to which SI lines. diagnosis was the best. When the primary condition is resolved, we should expect comparable imAccurate SI diagnosis requires: provement in absolute SI. Under the same cir-
• onset of the insomnia shortly follows that cumstances, partial SI will respond moderately well, of the primary condition and/or and specious SI not at all. Conversely, when at-
• variations in severity of the primary contempting to treat the sleep disturbance in SI directly, dition over time are shortly followed by (as several well-controlled studies have shown can comparable variations in the insomnia and/ effectively be done [52-54]), absolute SI should or respond poorly because as the insomnia improves,
• a clear causal mechanism (i.e. back pain it is replenished by the primary condition. Partial SI resulting in disrupted sleep). should respond moderately well, and specious SI SI is often multifactorial, and primary disorders should respond as well as PI.
can cause insomnia through: Which brings us to our final point. If our diag-
• physiological mechanisms (particularly true nostic tools do not permit reliable differentiation for neurological disorders). between absolute, partial and specious SI, then
• secondary symptoms (pain or nocturia). withholding or delaying direct insomnia treatment
• alerting medications used in treatment and/ while the ''primary'' condition is treated is ill advised.
or associated stress [6, 7] . This may inadvertently constitute denying effective sleep treatment to the patient and in some cases, residual benefits to the ''primary'' condition accruing to sleep improvement are also denied. We reResearch Agenda commend aggressive direct treatment of SI.
In the future we need to:
1. establish consistent and clear diagnostic cri-
SUMMARY AND CONCLUSIONS
teria. 2. further explore the effect of direct secondary Because SI is an extremely common condition, it's insomnia treatment on the primary disorder. accurate diagnosis and successful treatment has the potential to benefit significant numbers of patients.
3. continue to examine the efficacy of behavioral Primary insomnia (PI): poor sleep that is not the result of another disease, disorder, or substance. interventions, particularly in older adults. 4. investigate the efficacy of combining beRelaxation: a behavioral technique used to treat insomnia; includes any of a collection of methods havioral insomnia treatment with behavioral interventions known to be effective for speintended to evoke the relaxation response consisting of both experiential and physiological calm cific primary disorders, such as depression. 5. investigate the efficacy of various methods of [45] . Secondary insomnia (SI): poor sleep that results combining psychological and pharmacological treatments.
from another disease, disorder, or substance. Sleep efficiency (SE): ratio of total time slept to 6. determine whether the newer non-benzodiazepine hypnotics (zaleplon, zolpidem) the total time spent in bed multiplied by 100. of the conditions required for absolute SI is met, meaning the insomnia mimics the course of the primary condition in terms of either origin or vari- * The most important references are denoted by an asterisk.
ation in severity.
